- Home
- OCC vs COCP Comparison
OCC vs COCP Comparison
Compare OCC & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- COCP
- Stock Information
- Founded
- OCC 1983
- COCP N/A
- Country
- OCC United States
- COCP United States
- Employees
- OCC N/A
- COCP N/A
- Industry
- OCC Telecommunications Equipment
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- OCC Industrials
- COCP Health Care
- Exchange
- OCC Nasdaq
- COCP Nasdaq
- Market Cap
- OCC 17.2M
- COCP 18.3M
- IPO Year
- OCC 1996
- COCP N/A
- Fundamental
- Price
- OCC $2.20
- COCP $1.99
- Analyst Decision
- OCC
- COCP Strong Buy
- Analyst Count
- OCC 0
- COCP 1
- Target Price
- OCC N/A
- COCP $7.00
- AVG Volume (30 Days)
- OCC 10.2K
- COCP 14.9K
- Earning Date
- OCC 12-27-2024
- COCP 11-13-2024
- Dividend Yield
- OCC N/A
- COCP N/A
- EPS Growth
- OCC N/A
- COCP N/A
- EPS
- OCC N/A
- COCP N/A
- Revenue
- OCC $64,517,697.00
- COCP N/A
- Revenue This Year
- OCC N/A
- COCP N/A
- Revenue Next Year
- OCC N/A
- COCP N/A
- P/E Ratio
- OCC N/A
- COCP N/A
- Revenue Growth
- OCC N/A
- COCP N/A
- 52 Week Low
- OCC $2.02
- COCP $1.33
- 52 Week High
- OCC $3.53
- COCP $3.10
- Technical
- Relative Strength Index (RSI)
- OCC 40.87
- COCP 51.27
- Support Level
- OCC $2.05
- COCP $1.83
- Resistance Level
- OCC $2.24
- COCP $2.07
- Average True Range (ATR)
- OCC 0.13
- COCP 0.11
- MACD
- OCC 0.00
- COCP -0.01
- Stochastic Oscillator
- OCC 21.05
- COCP 44.74
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, broadcast, oil & gas, and others.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).